Kristine B Walhovd, Anders M Fjell, Øystein Sørensen, Athanasia Monika Mowinckel, Céline Sonja Reinbold, Ane-Victoria Idland, Leiv Otto Watne, Andre Franke, Valerija Dobricic, Fabian Kilpert, Lars Bertram, Yunpeng Wang
OBJECTIVE: To test the hypothesis that genetic risk for Alzheimer disease (AD) may represent a stable influence on the brain from early in life, rather than being primarily age dependent, we investigated in a lifespan sample of 1,181 persons with a total of 2,690 brain scans, whether higher polygenic risk score (PGS) for AD and presence of APOE ε4 was associated with lower hippocampal volumes to begin with, as an offset effect, or possibly faster decline in older age. METHODS: Using general additive mixed models, we assessed the relations of PGS for AD, including variants in APOE with hippocampal volume and its change in a cognitively healthy longitudinal lifespan sample (age range: 4-95 years, mean visit age 39...
October 2020: Neurology. Genetics